HIV Drug Based in Research by Sundquist Lab is Science’s 2024 Breakthrough of the Year
Lenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreLenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MorePreventing the protein’s activity causes parasites to die unusually rapidly.
Read MoreScientists are finding clues for how to treat diabetes and hormone disorders in a toxin from one of the most venomous animals on the planet.
Read More